Skip to main content

Table 4 RAM intervention improved health-related quality of life (HRQoL) in elderly patients with benign prostatic hyperplasia (BPH) undergoing transurethral resection of the prostate (TURP)

From: Perioperative care based on roy adaptation model in elderly patients with benign prostatic hyperplasia: impact on psychological well-being, pain, and quality of life

SF-36 parameters

T0

T1

T2

Physical functioning (PF)

   

Routine care group

64.84 ± 13.54

69.41 ± 14.06 *

75.29 ± 15.40 *#

RAM group

64.63 ± 14.10

74.06 ± 12.97 *

81.49 ± 11.46 *#

P

0.923

0.031

0.004

Physical role functioning (PRF)

   

Routine care group

60.55 ± 19.71

66.66 ± 17.18 *

75.30 ± 9.15 *#

RAM group

59.40 ± 19.31

72.15 ± 15.61 *

85.39 ± 8.49 *#

P

0.710

0.036

< 0.001

General health perceptions (GHP)

   

Routine care group

63.10 ± 17.02

68.86 ± 16.21 *

75.50 ± 12.29 *#

RAM group

63.43 ± 18.32

73.74 ± 14.30 *

82.30 ± 9.87 *#

P

0.908

0.045

< 0.001

Vitality (V)

   

Routine care group

58.75 ± 15.69

63.24 ± 16.49 *

72.58 ± 13.56 *#

RAM group

59.76 ± 15.94

68.76 ± 15.17 *

79.29 ± 10.90 *#

P

0.686

0.029

< 0.001

Social role functioning (SRF)

   

Routine care group

67.55 ± 16.86

68.10 ± 19.08

79.88 ± 9.97 *#

RAM group

66.10 ± 16.42

74.76 ± 13.64 *

83.80 ± 8.11 *#

P

0.582

0.012

0.007

Emotional role functioning (ERF)

   

Routine care group

60.54 ± 19.46

66.19 ± 16.44 *

72.60 ± 11.39 *#

RAM group

57.98 ± 18.29

71.31 ± 14.49 *

83.65 ± 10.15 *#

P

0.392

0.038

< 0.001

Mental health (MH)

   

Routine care group

70.18 ± 13.51

72.96 ± 15.02 *

80.21 ± 9.40 *#

RAM group

70.59 ± 13.17

77.8 ± 10.75 *

85.63 ± 6.85 *#

P

0.845

0.020

< 0.001

Bodily pain

   

Routine care group

64.91 ± 14.55

70.65 ± 14.79 *

81.68 ± 7.23 *#

RAM group

64.53 ± 15.35

76.05 ± 12.97 *

87.19 ± 7.78 *#

P

0.870

0.015

< 0.001

  1. Note: The data presented as mean ± standard deviation was collected at three time points: the preoperative visit (T0), at 30 days (T1), and at 3 months of follow-up (T2). Significant improvements were observed when comparing the data at T0 to both T1 and T2 (* P < 0.05). Furthermore, when comparing the data at T1 to T2, there were additional significant improvements (# P < 0.05)